We found no differences in age, sex, and comorbidities including hypertension, diabetes, dyslipidemia, chronic kidney disease, coronary artery disease, congestive heart failure, and smoking status between patients with low and high levels of AGP (Table 4). This evidence concerns the gene ATP5MK and metabolic syndrome.